Shah, V., Nowinski, S., Levi, D., Shinomiya, I., Kebaier Ep Chaabouni, N., Gillett, C., . . . Sawyer, E. J. (2017). PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression. Breast Cancer Res.
Chicago-stil citatShah, Vandna, et al. "PIK3CA Mutations Are Common in Lobular Carcinoma in Situ, but Are Not a Biomarker of Progression." Breast Cancer Res 2017.
MLA-referensShah, Vandna, et al. "PIK3CA Mutations Are Common in Lobular Carcinoma in Situ, but Are Not a Biomarker of Progression." Breast Cancer Res 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.